Jesse Brock Email & Phone Number

North Chicago, Illinois, US

New Haven, Connecticut, US

• Steering Early Opportunity Assessments across the entire early/mid-stage portfolio, with a focus in Oncology
• Supporting the development and Life-Cycle Management strategy for the Prostate Cancer program (ARV-110/766)
• Commercial lead for the KRAS G12D program, including Integrated Development Planning
• Led the IND-enabling Commercial Assessment for a first-in-class BCL6 targeted protein degrader in B-cell lymphoma
• Assist senior management with investor and board of directors meeting preparation (etc.)
• Built, expanded and own Competitive Intelligence programs for multiple Clinical and Pre-Clinical pipeline assets

New Haven, Connecticut, US

Lawrence Township, NJ, US

• Market Research (MR) Lead supporting Worldwide (WW) Multiple Myeloma Cell Therapy Customer and Market InsightsExpertise:
• Managing the WW Multiple Myeloma (MM) CAR T market research book-of-work, inclusive of pre-launch, post-launch and LCM activities in support of Abecma (ide-cel; bb2121)
• Delivering on a wide range of projects including, Demand (Opportunity), Concept (Communication), Objection Handling (Communication), Social Listening (Situation), Awareness Trial Usage (Performance) and Pulse.
• Stretch assignment(s): Delivering Tumor Strategy refreshes in Bladder Cancer and RCC to Commercial Oncology Strategy
• Mentored Graduate Fellow

Lawrence Township, NJ, US

• Competitive Intelligence (CI) Lead supporting US and WW Pan-Tumor Development and CommercializationExpertise:
• Leading primary and secondary CI for Early Assets, Biomarkers, Post-CPI, Cell Therapy and Dosing
• Communicating Competitive Intelligence across the WW and US Matrix Teams
• Providing end –to-end coverage for conferences, including development of coverage plans, in conference communications, intra-conference data debriefs and pre/post-conference competitive data reviews
• Teaming with Matrix Team Members to build novel landscapes and market POVs
• Developing analytic tools and methodologies to disproportionately impact speed and depth of insights

Lawrence Township, NJ, US

Lawrence Township, NJ, US

• Competitive Intelligence (CI) Lead supporting Commercial WW Hematology and CRC Expertise:
• Leading primary and secondary CI for Multiple Myeloma (MM), classic Hodgkin Lymphoma (cHL), Chronic Myeloid Leukemia (CML), Acute Myeloid Leukemia (AML), Non-Hodgkin's Lymphoma (NHL) and Colorectal Cancer (CRC)
• Collaborating with Business Development on short-term and long-term due diligence efforts
• Providing end –to-end coverage for conferences, including development of coverage plans, in conference communications, intra-conference data debriefs and pre/post-conference competitive data reviews
• Teaming cross functionally with Commercial Strategy, Business Development, Forecasting, Medical, Market Research and Brand Teams
• Developing analytic tools and methodologies to disproportionately impact speed and depth of insights

Boston, Massachusetts, US

• Topic expert in biopharma R&D, dedicated to investigating and analyzing challenges and opportunities across the industry.Expertise:
• Dedicated oncology point person charged with co-authoring whitepapers and synthesizing market intelligence reports
• Collaborated with client teams to deliver analyses across multiple topics including market landscaping, wholesale portfolio reviews and treatment algorithms
• Constructed a comprehensive market landscape analysis for Immuno-Oncology (IO), which helps clients understand "where to play" and "how to win" and is the foundation for a Nature Reviews Drug Discovery publication
• Supporting the development of a proprietary excel-based oncology tool designed to generate rapid pipeline, development and landscape insights; to be presented at ASCO 2017
• Go-to emerging technology expert having been staffed to CAR-T, microbiome and immuno-therapy (etc.) projects

Lowell, MA, US

Lowell, MA, US

• Advancing the development of a novel Rapid Microbiology Method; Revolutionizing the manufacturing process for Pharmaceutical, Biotech and Health Care products.Expertise:
• Accelerating cross-functional projects
• Liaising between engineering and scientific groups
• Developing highly integrated automated systems and disposable microbiology productsPublications:
• Select Rapid Micro Biosystems data presented via poster at the Annual PDA Meeting (2013)

Cambridge, Cambridgeshire, GB

• Contributed to the development of high-profile, antimicrobial compounds, targeted at unmet medical needs.Expertise:
• Small molecule Drug Discovery: Hit Identification and Lead Optimization
• Implementing significant process improvements to automated and robotic systems
• Execution of High-Throughput (HTS) and bench level assays in infectious diseasePublication:
• Jonge, B. L., Walkup, G. K., Lahiri, S. D., Huynh, H., Neckermann, G., Utley, L.,... Thresher, J. (2013). Discovery of Inhibitors of 4'-Phosphopantetheine Adenylyltransferase (PPAT) To Validate PPAT as a Target for.

Cambridge, Cambridgeshire, GB

New York, New York, US

Assisted the Microbial Science and Technology group, which was a subset of the Quality Control (QC) Microbiology department at Wyeth's (Pfizer) Andover, Massachusetts production facility.

Master Of Business Administration (Mba), Health Sector Management

Bachelor Of Science (Bs), Microbiology, General

Education record